2015 Antineoplastics

Drugs that target EGFR: CETUXIMAB/PANITUMUMAB, ERLOTINIB/GEFITINIB

Mechanisms of action

CETUXIMAB/PANITUMUMAB

ERLOTINIB (Tarceva/Genetech), GEFITINIB (Iressa/AstraZeneca)

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM